Pharmaledger
A portable supplier-evidence exchange that preserves source documents, official registry observations, reviewer findings, signatures, expiry and marketplace-specific acceptance while keeping qualification authority with each buyer and operator.
The supplied research confirms a single-company pharmaceutical supplier-verification competitor, enterprise healthcare merchant verification, public regulatory registers and no identified portable cross-marketplace dossier for contract manufacturers, research organizations and laboratories. It also confirms that two important regulatory registers have public web access but no stated REST interface. Pharmaledger's opportunity is evidence portability and adapter reuse, not a universal compliance credential. A signature proves bounded integrity and provenance; it does not prove that a document is authentic, current, applicable or sufficient for qualification.
A life-science procurement marketplace operator or supplier-quality team repeatedly collecting qualification evidence from contract manufacturers, research organizations and laboratories.
Portability must reduce duplication without flattening product, jurisdiction, buyer and quality-system differences.
Schemas, evidence manifests and marketplace adapters scale through software.
Open standards and public registers exist without proof of a newly removed barrier.
Repeated supplier evidence, public registers and cross-marketplace portability form a concrete B2B2B workflow and network hypothesis.
Buyer detail and timing are weak, qualification is marketplace-specific, important interfaces are unavailable, and regulatory evidence can be misread as compliance.
Discussion
No comments yet — be the first to weigh in.